Source - http://www.medicalnewstoday.com
Genetically Engineered Cells Can Transform Immune Cells Into Tumor Fighters In Humans
A team of researchers has genetically engineered normal immune cells to become specialized tumor fighters, demonstrating for the first time that these engineered cells can persist in the body and shrink large tumors in humans.
Two of the 17 people with advanced melanoma […]
This entry was posted on Monday, September 4th, 2006 at 6:40 pm and is filed under Latest News.
You can follow any responses to this entry through the RSS 2.0 feed.
You can , or trackback from your own site.
The UK is the only country in Europe where patients with metastatic colorectal cancer (mCRC) do not have routine access to Erbitux (cetuximab) a drug with potential to extend survival and even cure some people, it was revealed this week.
Erbitux approved in countries all over the world, thanks to a British-led study, is able to […]
This entry was posted on Thursday, July 20th, 2006 at 2:43 pm and is filed under Latest News.
You can follow any responses to this entry through the RSS 2.0 feed.
You can , or trackback from your own site.